Exacerbation of cancer pain after administering immune checkpoint inhibitor in a patient taking opioids: A case report.
Takahiro SumimotoRyota TanakaKen ShiraiwaRyosuke TatsutaHiroki ItohPublished in: Journal of clinical pharmacy and therapeutics (2021)
When administering immune checkpoint inhibitors such as nivolumab in clinical practice, the possibility of attenuation of opioid analgesic effect should be considered.